A useful GLP-1 consultation begins with your medical history, treatment goals and the exact proposed medicine. Ask about its approved indications, whether it fits your circumstances, relevant risks, alternatives and follow-up. Then confirm the pharmacy and total cost of continuing care before enrolling in a weight management program.
Which medicine is being discussed?
Wegovy contains semaglutide; Zepbound contains tirzepatide. These are examples of approved prescription medicines with defined indications and prescribing information. The ingredient name alone does not identify the brand, formulation or intended use being proposed.
Ask the clinician to explain why a particular option fits your situation and review the current product information with you. Approval does not mean a medicine is suitable for everyone. A general peptide menu is not a substitute for that individual assessment.
Sources: FDA: Zepbound approval announcement · Wegovy: current prescribing information
Bring the context needed for a medical decision
Bring prior treatment history, current medicines and supplements, allergies, and relevant medical and family history. Discuss pregnancy plans when relevant. Explain your goals in terms of health and everyday function, not only a target weight.
Ask how the plan includes nutrition, activity and reassessment, and what to do if treatment is poorly tolerated or unaffordable. The consultation should clarify which changes require contacting the prescriber; this guide does not provide a dosing or adjustment schedule.
Sources: FDA: Zepbound approval announcement · Wegovy: current prescribing information
Check the source and the continuity of care
FDA warns about unapproved GLP-1 products and recommends filling a clinician's prescription through a state-licensed pharmacy. Ask who dispenses the medicine, how to verify the label and whom to contact if the product or instructions are unclear.
If compounding is proposed, request the patient-specific reason and understand that it is not an FDA-approved generic. For Lakewood Ranch care, confirm where visits and any testing occur, then compare ongoing fees using the cost guide. Tell the practice if you expect to travel outside Florida during follow-up.
Sources: FDA: concerns with unapproved GLP-1 drugs · FDA: compounding questions and answers · Florida Department of Health: telehealth FAQs
Common questions
Can I choose a medicine from the advertised monthly price alone?
No. First establish which medicine and services the quote includes and whether the clinician considers the treatment appropriate.
Is compounded semaglutide an approved generic of Wegovy?
No. FDA distinguishes compounded preparations from approved generic drugs.
What should I clarify about follow-up?
Ask who reviews progress, how concerns are handled, which visits are required and what happens if your treatment plan changes.